Connect with us

Media OutReach

The National University Hospital and Ruijin Hospital, Shanghai Jiao Tong University School of Medicine establish key partnership for collaborative healthcare innovations

Published

on

Through the newly-formed Singapore-Shanghai Medical Innovation Centre, clinicians from both hospitals partner to advance breakthroughs in cell and gene therapy and orthopaedics for a start

SINGAPORE – Media OutReach Newswire – 16 October 2025 – In a step towards charting a new chapter in patient-centred innovations, the National University Hospital (NUH) and the Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (RJH) formally launched the Singapore-Shanghai Medical Innovation Centre (SSMIC) on 15 October at the 6th Singapore-Shanghai Comprehensive Cooperation Council (SSCCC) meeting in Shanghai, China.

Adj Prof Mark Edward Puhaindran, Chairman, Medical Board, National University Hospital (seated, third from left) and Prof Ning Guang, President, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (seated, fourth from left), at the launch of the Singapore-Shanghai Medical Innovation Centre on 15 Oct 2025.

The SSMIC marks the first project arising from the Memorandum of Understanding (MOU) signed by both hospitals during the 5th SSCCC meeting in 2024 , to establish a framework for clinical cooperation through staff exchange programmes and other collaborative efforts.
Co-chaired by Professor Aymeric Lim, Chief Executive Officer of NUH, and Professor Ning Guang, President of RJH, the SSMIC will serve as a dynamic space dedicated to co-developing proof-of-concept methodologies and medical technologies, exchange of critical expertise and ideas, and conducting vital translational research.
Elevating the patient care landscape
To begin this collaborative journey, the SSMIC will focus its efforts on priority tracks that draw upon the strengths and expertise of both NUH and RJH. This focused approach aims to deliver tangible results and accelerate innovations that will directly benefit patients, beginning with:
  • Cell and gene therapy
  • 3D printing in orthopaedics
Under cell and gene therapy, cancer experts from both hospitals will jointly conduct clinical trials to validate a novel Chimeric Antigen Receptor (CAR) T-cell therapy. Using a patient’s own immunity system to fight the cancer, this therapy employs a highly personalised form of treatment to destroy the cancer cells with the specific biomarker on their surface. The objective of this collaboration is to translate the findings of the trials into a validated, effective treatment that can be made available to suitable cancer patients, especially those who have not found success with first-line cancer treatments.
In the field of orthopaedics, specialists from NUH and RJH will launch a collaborative clinical study focusing on 3D printing’s transformative potential for musculoskeletal tumour resection and reconstruction of affected areas in patients’ bodies, to enhance surgical outcomes and improve patient recovery. This includes the design and implementation of patient-specific tumour prostheses, development of advanced 3D-printed bone-ingrowth segment scaffolds, and the use of bioprinted materials to address complex reconstructive needs arising from challenging cases such as after the removal of a large tumour.
While these initial projects represent a significant first step, they are just the beginning of what SSMIC sets out for patients. With the Centre designed to be a dynamic and sustained platform, NUH and RJH will actively explore opportunities for further collaborations and expand the Centre’s scope, ensuring a sustained pipeline of clinical breakthroughs.
“In the face of ever-evolving health challenges, it is paramount that we continuously innovate and push the boundaries of medical science” said Professor Aymeric Lim. “We are honoured to formalise this partnership with RJH as we build upon the foundation of collaboration established as founding members of the Asian University Hospital Alliance and as co-hosts at the 3rd Asian University Health Forum in December this year. Through the SSMIC, we look forward to partnering with RJH with a common mission to advance real-world change in healthcare, enriching the lives of individuals in both countries and beyond.”
“NUH shares the same value with Ruijin Hospital regardless of the geographic distance so our employees will do all we can to advance the clinical care and research to benefit more patients in more countries. Clinical excellence relies on long-term investment in people and lifelong reverence for the unknown. We as physicians and surgeons shall dedicate all we learn to the new cures; and mobilise the industry, the regulators, the basic scientists and other stakeholders to apply these cures to human at the fastest speed. This is also the call of SSMIC. With the support from Shanghai government and Singapore stakeholders, I have the faith that we will succeed.” said Professor NING Guang, President of Ruijin Hospital.

Hashtag: #NationalUniversityHospital




The issuer is solely responsible for the content of this announcement.

About the National University Hospital

The National University Hospital (NUH) is Singapore’s leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore.

About Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Ruijin Hospital was founded in 1907, formerly known as “Kuang-tse Hospital 廣慈醫院” and “Hôpital Sainte-Marie”, and is a public teaching hospital of Shanghai Jiao Tong University. The hospital boasts numerous medical experts with a high reputation both at home and abroad and runs full clinical specialties in Shanghai, Zhejiang, Jiangsu and Hainan Provinces. The headquarter is located in the city center of Shanghai City where the garden campus offers assuring mental and physical care for the people. Leading with solid research accomplishment and always curing the incurable, our faculty always meets the challenges in the no man’s land of medical technology. By mastering the cutting-edge therapy and adopting the team approach, we unite our strengths for the multidisciplinary treatment on the patients.
Ruijin Hospital established the official collaboration in 2024 under the government framework between Shanghai and Singapore. This partnership marks the fruit of the long-lasting medical exchange in two cities. Aiming to tackle more unmet needs in clinical, Ruijin Hospital will join NUH for more advanced cure in Asia and beyond.

Media OutReach

Holistic Way Unveils New Plant-Based Menopause Relief Supplement

Published

on

SINGAPORE – Media OutReach Newswire – 6 August 2026 – JR Life Sciences Pte Ltd, the company behind Singapore’s No. 1 Health-Supplement Brand, Holistic Way, announced the launch of its newest innovation in women’s health: a plant-based Menopause Relief supplement formulated to support women through every stage of menopause. The product is officially released this month, underscoring the company’s deepening commitment to addressing the evolving health needs of women in Singapore and across the region.

As awareness around women’s health continues to grow, menopause remains a life stage that is frequently underserved by mainstream health solutions. JR Life Sciences is responding to this gap with a science-backed, plant-derived formulation that offers a natural alternative to conventional hormone-based therapies, one that is both accessible and aligned with the preferences of today’s health-conscious consumer.

Menopause Relief is a once-daily capsule containing three plant-based phytoestrogens, each selected for their clinically studied benefits in managing menopause symptoms and supporting long-term health. The formulation is free from synthetic hormones and is suitable for both vegetarian and vegan diets, making it broadly accessible across diverse consumer lifestyles.

Key active ingredients include:

  • Lifenol Hops Extract (8-PN phytoestrogen): Shown to lessen hot flushes, night sweats, sleep disturbances, restlessness and irritability while helping to maintain total-body bone-mineral density.
  • Flax Lignan (SDG phytoestrogen): Provides gentle hormonal support that helps balance oestrogen levels during the transition.
  • Soy Isoflavone (genistein and daidzein): Supports bone strength, reduces hot flashes and steadies mild mood swings.

The launch of Menopause Relief reflects a broader strategic priority for JR Life Sciences: to expand its women’s health portfolio in response to growing consumer demand for natural health solutions. In Singapore, where an ageing population is driving increased interest in preventive health and targeted supplementation, the company sees a significant opportunity to better serve women navigating the menopause transition.

Holistic Way currently distributes a comprehensive range of nutraceuticals across key health categories, including:

As JR Life Sciences prepares for 2027, its focus remains on addressing unmet market needs and evolving consumer expectations. Guided by a commitment to science-backed innovation and quality, the company continues to invest in building a future-ready product pipeline that supports long-term well-being and reinforces trust among consumers in Singapore and beyond.

Menopause Relief is now available through Holistic Way’s retail and digital channels. For more information, visit https://holisticway.com.sg/.

Hashtag: #HolisticWay

The issuer is solely responsible for the content of this announcement.

About Holistic Way

Holistic Way is a leading Singapore-based health supplement brand under JR Life Sciences, committed to supporting holistic wellbeing through science-led nutrition. The brand offers a comprehensive range of supplements formulated to support key health areas, including immunity, hormonal balance, joint health, digestive wellness, and healthy ageing. Guided by evidence-based research and stringent quality standards, Holistic Way focuses on delivering effective, reliable solutions that address both everyday wellness needs and specific life-stage concerns. Through its emphasis on scientific integrity and product excellence, Holistic Way empowers individuals to take proactive control of their health and well-being.

Continue Reading

Media OutReach

VinFast’s Expansion Mirrors the Global Shift in EV Growth

Published

on

Emerging economies are becoming the EV industry’s fastest-growing markets, creating new opportunities for automakers with an international footprint. VinFast’s latest expansion reflects that shift.

DUBAI, UNITED ARAB EMIRATES – Media OutReach Newswire – 5 August 2026 – For much of the past decade, the global electric vehicle conversation has revolved around three markets: China, the United States, and Europe. But recent industry data suggests the next chapter may be written elsewhere.

In July, VinFast exported more than 5,000 electric vehicles aboard two dedicated vessels.

According to the International Energy Agency (IEA), global car sales fell about 5% in the first half of 2026 as economic pressures, fuel price volatility and policy changes weighed on demand in China and the US. Yet electric vehicle sales rebounded strongly in the second quarter, reaching record levels in 50 countries. Markets including Vietnam, India, Australia and South Korea roughly doubled EV sales compared with a year earlier, while more than 90 countries posted year-on-year growth during the first half of the year.

The shift reflects a broader change in where future industry growth is likely to come from. While China remains the world’s largest EV market, the IEA expects sales there to stagnate this year for the first time this decade, even as electric vehicles account for more than 60% of new car sales. Meanwhile, emerging markets are becoming increasingly important, supported by expanding policy incentives, growing charging infrastructure and rising consumer interest.

The agency also notes that China and other emerging economies are expected to account for around 60% of global car demand over the next decade, making success in these markets an increasingly important determinant of future automotive leadership.

VinFast’s latest performance reflects this changing landscape.

The Vietnamese automaker delivered 70,085 electric vehicles globally in the second quarter of 2026, up 96% year-on-year, bringing first-half deliveries to 128,662 vehicles, a 78% increase from the same period last year. The company’s two-wheel business also continued to expand rapidly, with 286,039 electric scooters and e-bikes delivered during the quarter, up 311% year-on-year.

The delivery mix also highlights the importance of products designed for diverse market needs. Models ranging from the compact VF 3 and VF 5 to the Limo Green MPV and the newly introduced VF MPV 7 all contributed meaningfully to second-quarter volumes, suggesting demand is spread across both personal mobility and commercial transportation segments.

Just as significant is where those vehicles are going.

In July, VinFast exported more than 5,000 electric vehicles aboard two dedicated vessels. One shipment, consisting of approximately 1,500 VF 6 SUVs, was designated for partner Green SM’s planned expansion in Europe, while another transported more than 3,500 vehicles to the Philippines and Indonesia. The voyages marked VinFast’s 37th and 38th international export shipments in fewer than four years, underscoring the increasing operational scale behind its global expansion.

VinFast’s effort in international market, including in the Middle East, shows that as growth becomes more geographically diversified, automakers can no longer rely on a handful of mature markets to drive expansion. Instead, success will increasingly depend on building products, distribution networks and operations that can compete across a wide range of emerging economies.

For the global EV industry, the center of gravity is not disappearing from established markets. It is becoming far more distributed. VinFast’s recent momentum suggests that companies positioned across multiple high-growth regions may be among the best placed to benefit from that shift.

Hashtag: #VinFast

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

EM Services and SPTel Partner to Advance Smart Estate Management Through Digital Connectivity and IoT Solutions

Published

on

SINGAPORE – Media OutReach Newswire – 5 August 2026 – EM Services and SPTel will formalise a strategic partnership to explore and deploy digital solutions that support smart estate management operations across Singapore, with the signing of a Memorandum of Understanding (MOU) on 6 August 2026.

The MOU signing will take place during the 29th SME Infocomm Commerce Conference (SMEICC), organised by the Singapore Chinese Chamber of Commerce and Industry (SCCCI) and held from 5 to 6 August 2026 at Suntec Singapore.

The collaboration brings together EM Services’ expertise in estate management with SPTel’s digital infrastructure capabilities, including resilient connectivity and Internet of Things (IoT) technologies.

As a first project under the partnership, EM Services and SPTel have deployed a Smart Rodent Monitoring solution at selected estates, with technology support from Cre8tec. The solution uses connected sensors and digital technologies to enable proactive monitoring of rodent activity, resulting in more timely intervention and more hygienic common spaces.

Beyond rodent monitoring, the partnership will explore how connectivity, IoT and emerging technologies can support future estate management applications. Potential areas include utilities monitoring, environmental monitoring and other smart estate solutions designed to improve operational efficiency and service delivery.

The collaboration also enables EM Services to work with industry partners, innovators and Institutes of Higher Learning (IHLs) to identify and pilot new technologies that can be scaled up to benefit estate operations and residents.

Through this partnership, EM Services and SPTel aim to deliver tangible benefits for both operations and residents, including:
  • Faster detection of estate issues
  • Faster response and resolution times
  • Better use of manpower and resources
  • Better services and living environments for residents

“At EM Services, we are continually exploring ways to enhance estate operations and improve the living environment for residents. Our partnership with SPTel brings together operational expertise and digital connectivity to support more proactive estate management. Starting with smart rodent monitoring, we look forward to exploring how technology and innovation can help us respond faster, deploy resources more effectively and deliver better outcomes for the communities we serve.”
Jen Tan
CEO
EM Services

“We are honoured to be selected by EM Services to power the next generation of smart townships in Singapore. This partnership reflects our shared commitment to advancing digital infrastructure as a foundational pillar for more connected, responsive, and sustainable communities.

By leveraging SPTel’s IoT-as-a-Service platform, LoRaWAN-enabled sensor network, edge cloud capabilities, and resilient connectivity, we are enabling the rapid deployment and scalable growth of smart township solutions. Together, we will turn data into actionable insights that deliver tangible outcomes and improve the quality of life for residents across Singapore”
Ernest Lee
Chief Executive Officer
SPTel

Hashtag: #EMServices #SPTel

The issuer is solely responsible for the content of this announcement.

About EM Services

EM Services is a leading integrated estate and facilities management company in Singapore, trusted by Town Councils and clients to manage complex estates and facilities. With nearly four decades of experience, the company combines deep operational experience with a broad range of technical and professional expertise, supported by established systems, technology and extensive on-the-ground operations. Through strong partnerships and operational excellence, EM Services supports reliable service delivery and safer, cleaner and greener environments for the communities its clients serve.

For more information, please visit .

About SPTel

SPTel uses unique fibre pathways laid alongside the power network cables to deliver resilient, business class digital services. As a leading provider of next-generation telecommunications and digital solutions SPTel places a strong focus on innovation and reliability. This enables SPTel to deliver secure and scalable connectivity, edge cloud, IoT-as-a-Service, Quantum-Safe Networking and managed security solutions to businesses, government agencies, and service providers. SPTel is committed to driving digital transformation by providing cutting-edge technologies and exceptional customer experiences.

For more information, please visit .

Continue Reading